Bronchopulmonary dysplasia. Impact of surfactant replacement therapy (Q44009434)

28 November 2017

1 reference

title

Bronchopulmonary dysplasia. Impact of surfactant replacement therapy (English)

1 reference

bronchopulmonary dysplasia

28 November 2017

main subject

1 reference

1

S. A. McColley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9653437

29 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9653437

29 December 2024

publication date

1 June 1998

1 reference

28 November 2017

June 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9653437

full work available at URL

29 December 2024

https://api.elsevier.com/content/article/PII:S0031395505700286?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

https://api.elsevier.com/content/article/PII:S0031395505700286?httpAccept=text/plain

29 December 2024

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Pediatric Clinics of North America

29 December 2024

published in

1 reference

28 November 2017

volume

45

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

573-586

1 reference

Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Lung function eight years after neonatal ventilation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Childhood sequelae of infant lung disease: exercise and pulmonary function abnormalities after bronchopulmonary dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Decreased sodium ion absorption across nasal epithelium of very premature infants with respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Annual audit of neonatal morbidity in preterm infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Reduction in the risk of bronchopulmonary dysplasia from 1980–1990: Results of a multivariate logistic regression analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Surfactant therapy prior to the interhospital transport of preterm infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Bronchopulmonary dysplasia and very low birthweight: lung function at 11 years of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Effects of surfactant therapy on outcome of infants with birth weights of 600 to 750 grams

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Immediate improvement in lung volume after exogenous surfactant: alveolar recruitment versus increased distention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Influence of clinical and ventilatory parameters on morphology of bronchopulmonary dysplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

A multicenter randomized controlled clinical trial of bovine surfactant for prevention of respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

A European multicenter randomized controlled trial of single dose surfactant therapy for idiopathic respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Pulmonary surfactant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Spectrum of oxygen dependency in surviving infants weighing 600 to 1000 grams: decreased incidence of severe chronic lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Prophylactic treatment of very premature infants with human surfactant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Late pulmonary sequelae of bronchopulmonary dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Calf lung surfactant extract prophylaxis and retinopathy of prematurity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Long term effects of artificial ventilation in neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

The lungs in immature infants: how important is surfactant therapy in preventing chronic lung problems?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Ten Centre Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Neurosensory outcome at 5 years and extremely low birthweight. The Victorian Infant Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Porcine surfactant replacement therapy in newborns of 25-31 weeks' gestation: a randomized, multicentre trial of prophylaxis versus rescue with multiple low doses. The French Collaborative Multicentre Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Ureaplasma urealyticum and chronic lung disease of prematurity: critical appraisal of the literature on causation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

The relationship of childhood respiratory illness to adult obstructive airway disease

7 January 2021

10

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Surfactant replacement therapy at birth: final analysis of a clinical trial and comparisons with similar trials

29 December 2024

38

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Respiratory illnesses in survivors of infant respiratory distress syndrome

29 December 2024

48

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

Incidence of bronchopulmonary dysplasia during an 11-year period in infants weighing less than 1500 g at birth

29 December 2024

68

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(05)70028-6

29 December 2024

Identifiers

1 reference

28 November 2017

1 reference